COVID-19 Antigen Test @Home is an FDA EUA lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2
Features and Benefits:
Positive Percent Agreement (PPA) – 82.5%
Negative Percent Agreement (NPA) – 100%
Non-Invasive – Anterior nasal swab specimens; no need to swab deep in the nasal cavity for sample collection
Easy to Use – Simple 4-step process from sample collection to results
